Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,340
Closed -$594K 911
2024
Q4
$594K Buy
3,340
+140
+4% +$25.7K 0.03% 498
2024
Q3
$632K Sell
3,200
-1,800
-36% -$336K 0.03% 419
2024
Q2
$858K Buy
+5,000
New +$828K 0.04% 326
2023
Q4
Sell
-2,489
Closed -$371K 793
2023
Q3
$371K Buy
+2,489
New +$365K 0.02% 454
2022
Q4
Sell
-3,500
Closed -$470K 930
2022
Q3
$470K Sell
3,500
-762
-18% -$109K 0.02% 535
2022
Q2
$653K Hold
4,262
0.03% 514
2022
Q1
$691K Sell
4,262
-4,066
-49% -$591K 0.03% 530
2021
Q4
$1.13M Buy
8,328
+500
+6% +$59.1K 0.04% 391
2021
Q3
$845K Buy
7,828
+2,500
+47% +$286K 0.04% 455
2021
Q2
$600K Sell
5,328
-993
-16% -$112K 0.02% 570
2021
Q1
$684K Buy
+6,321
New +$676K 0.03% 492
2019
Q4
Sell
-2,899
Closed -$220K 645
2019
Q3
$220K Hold
2,899
0.01% 431
2019
Q2
$211K Hold
2,899
0.01% 434
2019
Q1
$234K Hold
2,899
0.01% 409
2018
Q4
$267K Hold
2,899
0.02% 354
2018
Q3
$274K Sell
2,899
-24,726
-90% -$2.34M 0.01% 380
2018
Q2
$2.56M Buy
+27,625
New +$2.7M 0.12% 126
2017
Q1
Sell
-11,654
Closed -$730K 628
2016
Q4
$730K Hold
11,654
0.04% 290
2016
Q3
$735K Hold
11,654
0.04% 306
2016
Q2
$721K Sell
11,654
-2,998
-20% -$183K 0.05% 282
2016
Q1
$837K Sell
14,652
-7,012
-32% -$391K 0.05% 264
2015
Q4
$1.28M Sell
21,664
-5,000
-19% -$288K 0.08% 212
2015
Q3
$1.45M Sell
26,664
-6,812
-20% -$443K 0.09% 199
2015
Q2
$2.25M Buy
33,476
+26,283
+365% +$1.72M 0.1% 186
2015
Q1
$421K Hold
7,193
0.02% 469
2014
Q4
$471K Hold
7,193
0.02% 450
2014
Q3
$415K Sell
7,193
-9,463
-57% -$525K 0.02% 517
2014
Q2
$940K Hold
16,656
0.04% 337
2014
Q1
$856K Hold
16,656
0.04% 305
2013
Q4
$880K Buy
+16,656
New +$819K 0.04% 301

Other funds holding ABBV

CSS LLC's ABBV Position: Q1 2025 in Review

CSS LLC sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 3,340 shares — an estimated $594K sold.

CSS LLC first reported a position in ABBV in Q4 2013 and held it in 30 quarters. The position peaked at $2.56M in Q2 2018. 3,826 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • CSS LLC reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • CSS LLC sold 3,340 AbbVie shares in Q1 2025, an estimated $594K.
  • CSS LLC first reported a position in AbbVie in Q4 2013 and held it in 30 quarters.
  • CSS LLC's AbbVie position peaked at $2.56M in Q2 2018.
  • 3,826 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.